Skip to main content
. 2020 Jun 4;21(11):4012. doi: 10.3390/ijms21114012
ASLE advanced adenocarcinoma of the stomach and lower esophagus
CA 15-3 carbohydrate antigen 15-3
CA 19-9 carbohydrate antigen 19-9
CA 72-4 carbohydrate antigen 72-4
CDH1 cadherin 1 gene
CEA carcinoembryonic antigen
EBV Epstein-Barr virus
ECF epirubicin, cisplatin, and infused fluorouracil
EOGC early-onset gastric cancer
EPIC early postoperative intraperitoneal chemotherapy
ESD endoscopic submucosal dissection
FAMTX fluorouracil, doxorubicin, and methotrexate
FP 5-fluorouracil and cisplatin
GC gastric cancer
GSC gastric stump cancer
H. pylori Helicobacter pylori
HDGC hereditary diffuse gastric cancer
HIIC hyperthermic intraoperative intraperitoneal chemotherapy
HIPEC hyperthermic intraperitoneal chemotherapy
MSI microsatellite instability
PIPAC pressurized intraperitoneal aerosol chemotherapy
PUD peptic ulcer disease